EUVIMEDEUVIMED entdecken
Open Access

Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A–Lymphoid Enhancer–Binding Factor 1–Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia

Christina Sharkey, Boqing Gu, Xingbo Long, Yao Tang, Nicolas Patsatzis, Steven Li, Aria F Olumi, Zongwei Wang

The American Journal of Pathology · 2025

DOI: 10.1016/j.ajpath.2025.08.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2025. Verfasst von Christina Sharkey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, 3-Oxo-5-alpha-Steroid 4-Dehydrogenase, Wnt-5a Protein, Insulin-Like Growth Factor I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Hyperplasia3-Oxo-5-alpha-Steroid 4-DehydrogenaseWnt-5a ProteinInsulin-Like Growth Factor IProstateMembrane ProteinsMaleHumansAnimalsMiceSignal TransductionStromal CellsCell ProliferationMice, Knockout

Substanzen

3-Oxo-5-alpha-Steroid 4-DehydrogenaseWnt-5a ProteinSRD5A2 protein, humanInsulin-Like Growth Factor IWNT5A protein, humanMembrane ProteinsIGF1 protein, human

Autor:innen und Institutionen

  • Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China; State Key L…
  • College of Natural Sciences, The University of Texas at Austin, Austin, Texas.
  • College of Computer Sciences, Washington University, St. Louis, Missouri.
  • Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: zwang12@bidmc.harvard.edu.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Sharkey, C., Gu, B., Long, X., Tang, Y., Patsatzis, N., Li, S., Olumi, A. F., & Wang, Z. (2025). Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A–Lymphoid Enhancer–Binding Factor 1–Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2025.08.011

Vancouver

Sharkey C, Gu B, Long X, Tang Y, Patsatzis N, Li S, et al. Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A–Lymphoid Enhancer–Binding Factor 1–Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia. The American Journal of Pathology. 2025. doi:10.1016/j.ajpath.2025.08.011

BibTeX
@article{Sharkey2025,
  author = {Sharkey, Christina and Gu, Boqing and Long, Xingbo and Tang, Yao and Patsatzis, Nicolas and Li, Steven and Olumi, Aria F and Wang, Zongwei},
  title = {Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A–Lymphoid Enhancer–Binding Factor 1–Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia},
  journal = {The American Journal of Pathology},
  year = {2025},
  doi = {10.1016/j.ajpath.2025.08.011}
}
Kostenlos starten →